top of page

Creative Director • Copywriter • Director

Intellia 

CRISPR:  Hereditary Angioedema (HAE) 

Freelance Copywriter/Creative Director

Unbranded

Rare Diseases - New Business Pitch

Intellia was looking for a partner to bring NTEL-2021 and NTEL-2022 to market.  These CRISPR-based therapies are genuinely transformative treatments that will usher in a new era for rare genetic diseases such as HAE, ATTR-CM, and ATTR-PN.  Beyond rare diseases, the launch of gene editing treatments will be an inflection point in all of healthcare. But the idea of editing one’s genetic code still feels sci-fi and frightening to many.  The objective was to make the significance of the CRISPR therapies clear while simultaneously letting patients see them feel like a natural step, not something from the future, but something from their lives.  

bottom of page